Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local botulinum toxin injection in Parkinson's disease
IRCT20100127003217N11Phase 4Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Feb 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of neuronox in Parkinson's disease (PD), sponsored by Tabriz University of Medical Sciences. Started Feb 2019; status: completed.
02
Drugs
neuronox
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on IRCT20100127003217N11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20100127003217N11.